TALENoffer: Genome-wide TALEN off-target prediction

Bioinformatics

Volumn 29, Issue 22, 2013, Pages 2931-2932

  Grau, Jan ^a   Boch, Jens ^a   Posch, Stefan ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; DNA BINDING PROTEIN;

ANIMAL; ARTICLE; COMPUTER PROGRAM; GENOME; METABOLISM; MUTAGENESIS; PROTEIN ENGINEERING; STATISTICAL MODEL;

ANIMALS; DNA-BINDING PROTEINS; ENDODEOXYRIBONUCLEASES; GENOME; MODELS, STATISTICAL; MUTAGENESIS; PROTEIN ENGINEERING; SOFTWARE;

EID: 84888090695     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt501     Document Type: Article

References (13)

1. Blankenberg, D. et al. (2010) Galaxy: A Web-Based Genome Analysis Tool for Experimentalists. Curr. Protoc. Mol. Biol., 89, 19.10.1-19.10.21.
2. Boch, J. et al. (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 326, 1509-1512.
3. Doyle, E.L. et al. (2012) TAL effector-nucleotide targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res., 40, W117-W122.
4. Gaj, T. et al. (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol., 31, 397-405.
5. Grau, J. et al. (2013) Computational predictions provide insights into the biology of TAL effector target sites. PLoS Comput. Biol., 9, e1002962.
6. Grau, J. et al. (2012) Jstacs: a Java framework for statistical analysis and classification of biological sequences. J. Mach. Learn. Res., 13, 1967-1971.
7. Hockemeyer, D. et al. (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol., 29, 731-734.
8. Miller, J.C. et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol., 29, 143-148.
9. Moscou, M.J. and Bogdanove, A.J. (2009) A simple cipher governs DNA recognition by TAL effectors. Science, 326, 1501.
10. Mussolino, C. et al. (2011)AnovelTALEnuclease scaffold enableshigh genomeediting activity in combination with low toxicity. Nucleic Acids Res., 39, 9283-9293.
11. Osborn, M.J. et al. (2013) TALEN-based gene correction for epidermolysis bullosa. Mol. Ther., 21, 1151-1159. doi:10.1038/mt.2013.56.
12. Streubel, J. et al. (2012) TAL effector RVD specificities and efficiencies. Nat. Biotechnol., 30, 593-595.
13. Tesson, L. et al. (2011) Knockout rats generated by embryo microinjection of TALENs. Nat. Biotechnol., 29, 695-696.